Translational Research in the Development of Bortezomib: A Core Model - Ibis Sanchez-Serrano - Discovery Medicine
IJMS | Free Full-Text | Cellular Responses to Proteasome Inhibition: Molecular Mechanisms and Beyond | HTML
Updates to the drug‐resistant mechanism of proteasome inhibitors in multiple myeloma - Bai - 2021 - Asia-Pacific Journal of Clinical Oncology - Wiley Online Library
Enhancing activity and overcoming chemoresistance in hematologic malignancies with bortezomib: preclinical mechanistic studies - Annals of Oncology
Resistance Mechanisms to Novel Therapies in Myeloma | IntechOpen
Higher proteotoxic stress rather than mitochondrial damage is involved in higher neurotoxicity of bortezomib compared to carfilzomib - ScienceDirect
Frontiers | Carfilzomib: A Promising Proteasome Inhibitor for the Treatment of Relapsed and Refractory Multiple Myeloma | Oncology
A novel orally active proteasome inhibitor induces apoptosis in multiple myeloma cells with mechanisms distinct from Bortezomib: Cancer Cell
Suggested mechanism of the combination of IGF-I and bortezomib in... | Download Scientific Diagram
Pharmacology, Pharmacokinetics, and Practical Applications of Bortezomib
Bortezomib in mantle cell lymphoma | Future Oncology
Mechanism of Action of Bortezomib and the New Proteasome Inhibitors on Myeloma Cells and the Bone Microenvironment: Impact on Myeloma-Induced Alterations of Bone Remodeling
Kyprolis FOCUS Phase 3 Study for Multiple Myeloma | Cancer Biology
Preclinical evaluation of the proteasome inhibitor bortezomib in cancer therapy | Cancer Cell International | Full Text
A novel proteasome inhibitor NPI-0052 as an anticancer therapy | British Journal of Cancer
Mechanism of action of proteasome inhibitors and deacetylase inhibitors and the biological basis of synergy in multiple myeloma. - Abstract - Europe PMC
Kyprolis FOCUS Phase 3 Study for Multiple Myeloma | Cancer Biology
Bortezomib - Wikipedia
Bortezomib | Nature Reviews Drug Discovery
![PDF] Mechanism of action of bortezomib in multiple myeloma therapy | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/4ebf99daf8ab626dcd9b5964608b3fb9df76f309/2-Figure1-1.png "PDF] Mechanism of action of bortezomib in multiple myeloma therapy | Semantic Scholar")
PDF] Mechanism of action of bortezomib in multiple myeloma therapy | Semantic Scholar
Preclinical evaluation of the proteasome inhibitor bortezomib in cancer therapy | Cancer Cell International | Full Text
JAMA Internal Medicine on Twitter: "In this review, we learn that immunomodulatory drugs (thalidomide, lenalidomide) and proteasome inhibitors (bortezomib, carfilzomib, ixazomib) have improved the overall survival of patients with #multiplemyeloma (MM ...
Advances in the Understanding of Mechanisms and Therapeutic Use of Bortezomib - Taskeen Mujtaba - Discovery Medicine
Rationale for the treatment of solid tumors with the proteasome inhibitor bortezomib - Cancer Treatment Reviews
Proteasome Inhibitors
Mechanism of antitumour activity of bortezomib in multiple myeloma (MM)... | Download Scientific Diagram
IJMS | Free Full-Text | Pathological Mechanisms of Bortezomib-Induced Peripheral Neuropathy | HTML
